These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6651401)

  • 21. A novel 5-HT(2) antagonist, sarpogrelate hydrochloride, shows inhibitory effects on both contraction and relaxation mediated by 5-HT receptor subtypes in porcine coronary arteries.
    Gong H; Nakamura T; Hattori K; Ohnuki T; Rashid M; Nakazawa M; Watanabe K; Nagatomo T
    Pharmacology; 2000 Nov; 61(4):263-8. PubMed ID: 11093079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ischemic cardiopathy with patent epicardial coronary arteries. Vasomotricity of the arterioles of the heart].
    Ribeiro Jorge PA; de Camargo AM
    Arq Bras Cardiol; 1987 Jul; 49(1):9-14. PubMed ID: 3450259
    [No Abstract]   [Full Text] [Related]  

  • 23. Augmentation of vasoconstrictor responses to serotonin by acute and chronic factors: inhibition by ketanserin.
    Van Nueten JM; Janssens WJ
    J Hypertens Suppl; 1986 Apr; 4(1):S55-9. PubMed ID: 2939213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The mechanism of ergonovine-induced airway smooth muscle contraction].
    Sakamoto Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jun; 27(6):679-88. PubMed ID: 2796062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ketanserin and vascular contractions in response to cooling.
    Van Nueten JM; De Ridder W; Vanhoutte PM
    Eur J Pharmacol; 1984 Apr; 99(4):329-32. PubMed ID: 6734731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective hypercontraction caused by ergonovine in the canine coronary artery under conditions of induced atherosclerosis.
    Kawachi Y; Tomoike H; Maruoka Y; Kikuchi Y; Araki H; Ishii Y; Tanaka K; Nakamura M
    Circulation; 1984 Feb; 69(2):441-50. PubMed ID: 6690109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of ergonovine-induced hyperconstriction of the large epicardial coronary artery in conscious dogs a month after arterial injury.
    Egashira K; Tomoike H; Hayashi Y; Yamada A; Nakamura M; Takeshita A
    Circ Res; 1992 Aug; 71(2):435-42. PubMed ID: 1628398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Augmentation of coronary responsiveness to serotonin at the site of X-ray-induced intimal thickening in miniature pigs.
    Mitsuoka W; Egashira S; Tagawa H; Kuga T; Hayashi Y; Yamada A; Tomoike H; Nakamura M; Takeshita A
    Cardiovasc Res; 1995 Aug; 30(2):246-54. PubMed ID: 7585812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin-induced vasoconstriction in dog kidney.
    Takahashi T; Hisa H; Satoh S
    J Cardiovasc Pharmacol; 1992; 20(5):779-84. PubMed ID: 1280741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Coronary artery spasm induced in humans by ergonovine maleate].
    Specchia G; Valsecchi O; De Servi S; Bramucci E; Gavazzi A
    Boll Soc Ital Biol Sper; 1977 Sep; 53(17):1452-8. PubMed ID: 607955
    [No Abstract]   [Full Text] [Related]  

  • 31. Serotonin-induced vasoconstriction in the perfused canine femoral artery can be blocked in vivo by ketanserin.
    Meschig R; Breuer J; Arnold G
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S56-9. PubMed ID: 2412060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential inhibition by ergonovine of norepinephrine release in the coronary artery and saphenous vein of the dog.
    O'Rourke ST; Vanhoutte PM
    J Pharmacol Exp Ther; 1989 Apr; 249(1):52-5. PubMed ID: 2709336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperreactivity of coronary arterial smooth muscles in response to ergonovine from rabbits with hereditary hyperlipidemia.
    Yokoyama M; Akita H; Mizutani T; Fukuzaki H; Watanabe Y
    Circ Res; 1983 Jul; 53(1):63-71. PubMed ID: 6861297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the serotonin receptors that mediate smooth muscle contraction in canine and porcine coronary artery.
    Cushing DJ; Cohen ML
    J Pharmacol Exp Ther; 1992 Jun; 261(3):856-62. PubMed ID: 1602389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular pharmacology of ketanserin.
    Van Nueten JM; Vanhoutte PM
    Bibl Cardiol; 1984; (38):222-33. PubMed ID: 6099724
    [No Abstract]   [Full Text] [Related]  

  • 36. ICI 169,369 is both a competitive antagonist and an allosteric activator of the arterial 5-hydroxytryptamine2 receptor system.
    Kaumann AJ; Frenken M
    J Pharmacol Exp Ther; 1988 Jun; 245(3):1010-5. PubMed ID: 3385635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular activity of ketanserin (R 41 468), a selective 5-HT2 receptor antagonist.
    Van Nueten JM; Xhonneux R; Vanhoutte PM; Janssen PA
    Arch Int Pharmacodyn Ther; 1981 Apr; 250(2):328-9. PubMed ID: 7271395
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of serotonin and its antagonist ketanserin on pial vessels.
    Auer LM; Leber K; Sayama I
    J Cereb Blood Flow Metab; 1985 Dec; 5(4):517-22. PubMed ID: 2932453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasoconstrictor mechanism of 5-hydroxytryptamine in isolated and perfused canine basilar arteries.
    Tsuji T; Chiba S
    Arch Int Pharmacodyn Ther; 1987 Mar; 286(1):111-22. PubMed ID: 3592852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effects of nisoldipine on serotonin and potassium induced contractions of porcine coronary and femoral arteries.
    Kazda S
    Arzneimittelforschung; 1991 Mar; 41(3):204-7. PubMed ID: 1867655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.